Occupational Activity – Page 16

Trump Revokes Biden’s Executive Order on AI Safety and Trustworthiness

8 months ago talkbio0Tagged Administration occupational activities, AI safety, Aortic Valve Insufficiency, Artificial (qualifier value), Biden Executive Order, governance, Regulation, Transplant Registry Unified Management Program

AI Safety, Biden Executive Order, Trump Administration, Artificial Intelligence Governance, AI Regulation

Sionna and Odyssey Therapeutics Kick Off 2025 Biotech IPO Wave with SEC Filings

8 months ago talkbio0Tagged 2025, File (record), Health care facility, Industry, IPO, JPM, Market, Odyssey, Sionna

Sionna Therapeutics, Odyssey Therapeutics, IPO filings, biotech industry, JPM Healthcare Conference, 2025 IPO market

Understanding the Second Round of Medicare Drug Price Negotiations: What Trump’s CMS Can and Can’t Change

8 months ago talkbio0Tagged Administration occupational activities, CMS, drug price, Inflation, Medicare, Myasthenic Syndromes, Congenital, negotiation, Prices, Transplant Registry Unified Management Program

Medicare drug price negotiation, Trump administration, CMS, Inflation Reduction Act, drug prices, negotiation process

Charles River Laboratories Forecasts Revenue Decline in 2025 Amid CDMO Challenges

8 months ago talkbio0Tagged 2025, Biopharma, business career, CDMO, Charles, constraints, Drug Industry, IL31RA gene, revenue outlook, River Laboratories, spending, trends qualifier

Charles River Laboratories, CRL, 2025 revenue outlook, CDMO business challenges, biopharma spending constraints, pharmaceutical industry trends

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

8 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

GSK Advances Liver Disease Research and Biotech CEO Sisterhood Grows Influence

8 months ago talkbio0Tagged biotech, CEO, Drug Industry, JPM25, Liver diseases, sisterhood, SmithKline Beecham, Women

GSK, liver disease, Biotech CEO Sisterhood, JPM25, pharmaceutical industry, women in biotech

Key Takeaways from #JPM25: Strategic Partnerships and Acquisitions Dominate the JP Morgan Healthcare Conference

8 months ago talkbio0Tagged Acquisitions, Biopharma, Eli, Eli Lilly, Industry, J.P. Morgan Healthcare, JPM25, partnerships, Pharma, Scorpions, SmithKline Beecham, Zealand

JP Morgan Healthcare Conference, #JPM25, biopharma industry, acquisitions, partnerships, Eli Lilly, Zealand Pharma, GSK, Scorpion Therapeutics

IGM Biosciences Halts Autoimmune Projects Amid Layoffs Following Disappointing Trial Data

8 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, bispecific antibody T cell, engagers, IGM-2644, Immunoglobulin M, imvotamab, Industry

IGM Biosciences, layoffs, autoimmune diseases, bispecific antibody T cell engagers, imvotamab, IGM-2644, biotech industry

Revance Therapeutics Faces Competing Buyout Offers: Teoxane SA Outbids Crown Laboratories

8 months ago talkbio0Tagged Biotechnology, Crown Laboratories, Industry, Revance, sulfanilamide, Teoxane

Revance Therapeutics, Teoxane SA, Crown Laboratories, buyout offers, merger agreement, biotechnology, skincare industry

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

8 months ago talkbio0Tagged asset, Biological Factors, BIOSECURE, Dundalk, Facility (object), Ireland, Merck, regulatory, Sales - occupational activity, strategic shift, Vaccines, WuXi

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act